U.S., Nov. 3 -- ClinicalTrials.gov registry received information related to the study (NCT07909395) titled 'Cardiovascular Disease Multimorbidity' on Oct. 19.
Brief Summary: This is a hybrid type II effectiveness-implementation trial using a parallel cluster randomized design. Thirty primary healthcare centers (PHCs) in Akwa Ibom State, Nigeria, will be randomized in a 1:1 ratio to the implementation group (Practice Facilitation [PF] + Healthy Lifestyle Counselling, Evidence-Based Protocols, Access to Essential Medicines and Technology, Risk-Based Management, Team-Based Care, and Systems for Monitoring [HEARTS] package) or the standard care group (HEARTS only)
The study comprises two phases: an R61 Initiation Phase (Years 1-2) involving a...